• American Headache Society president: ‘Exciting, cautious' time for patients with migraine

    8 monthes ago - By Healio

    The 89 drugs that have received FDA approval since January 2017, when limiting these drugs' scope to the drug's primary indication, suggests significant attention for those patients with migraine. Only those patients with various types of cancer have benefitted more.
    Three agents intended to prevent migraine - the injections Aimovig, Ajovy and Emgality - have come in the last 5 months, with the last two receiving the green light within the past 3 weeks.
    Kathleen Digre, MD, FAHS, president of the American Headache Society, explained how the migraine-related approvals are
    Read more ...